Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
On the 30th of September WHO issued a early release of "Guideline on when to start ARVs" It includes two key recommendations with major potential implications on HIV treatment and prevention scale up worldwide.
1) Antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count.
2) The use of daily oral pre-exposure prophylaxis (PrEP) is recommended as a prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches.